National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

mafosfamide
A synthetic oxazaphosphorine derivative with antineoplastic properties. Mafosfamide alkylates DNA, forming DNA cross-links and inhibiting DNA synthesis. Although closely related to cyclophosphamide, mafosfamide, unlike cyclophosphamide, does not require hepatic activation to generate its active metabolite 4-hydroxy-cyclophosphamide; accordingly, mafosfamide is potentially useful in the intrathecal treatment of neoplastic meningitis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:Lyovac Cosmegen, Lyrica, lyso-thermosensitive liposome doxorubicin, Lysodren, m-azidopyrimethamine
Next:MAGE-10.A2, MAGE-A3/HPV 16 peptide vaccine, magnesium citrate, magnesium hydroxide, magnesium valproate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov